248 related articles for article (PubMed ID: 15893618)
1. Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge.
Karaca K; Bowen R; Austgen LE; Teehee M; Siger L; Grosenbaugh D; Loosemore L; Audonnet JC; Nordgren R; Minke JM
Vaccine; 2005 May; 23(29):3808-13. PubMed ID: 15893618
[TBL] [Abstract][Full Text] [Related]
2. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
[TBL] [Abstract][Full Text] [Related]
4. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
[TBL] [Abstract][Full Text] [Related]
5. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
6. Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus).
Langevin SA; Arroyo J; Monath TP; Komar N
Am J Trop Med Hyg; 2003 Jul; 69(1):78-80. PubMed ID: 12932102
[TBL] [Abstract][Full Text] [Related]
7. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
8. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
9. Equine vaccine for West Nile virus.
Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
[TBL] [Abstract][Full Text] [Related]
11. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
Minke JM; Siger L; Karaca K; Austgen L; Gordy P; Bowen R; Renshaw RW; Loosmore S; Audonnet JC; Nordgren B
Arch Virol Suppl; 2004; (18):221-30. PubMed ID: 15119777
[TBL] [Abstract][Full Text] [Related]
12. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.
Siger L; Bowen RA; Karaca K; Murray MJ; Gordy PW; Loosmore SM; Audonnet JC; Nordgren RM; Minke JM
Am J Vet Res; 2004 Nov; 65(11):1459-62. PubMed ID: 15566080
[TBL] [Abstract][Full Text] [Related]
14. Serological evidence of West Nile virus in dogs and cats in China.
Lan D; Ji W; Yu D; Chu J; Wang C; Yang Z; Hua X
Arch Virol; 2011 May; 156(5):893-5. PubMed ID: 21221671
[TBL] [Abstract][Full Text] [Related]
15. Lack of detectable West Nile virus RNA in brains and kidneys of dogs and cats with immunohistological precipitates using virus-specific antibodies.
Schaudien D; Schwab S; Linke S; Seeliger F; Pauli G; Baumgärtner W; Herden C
Vet Microbiol; 2008 Nov; 132(1-2):171-6. PubMed ID: 18572333
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.
Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
[TBL] [Abstract][Full Text] [Related]
18. Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis).
Redig PT; Tully TN; Ritchie BW; Roy AF; Baudena MA; Chang GJ
Am J Vet Res; 2011 Aug; 72(8):1065-70. PubMed ID: 21801064
[TBL] [Abstract][Full Text] [Related]
19. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
[TBL] [Abstract][Full Text] [Related]
20. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
Grosenbaugh DA; Leard T; Pardo MC
J Am Vet Med Assoc; 2006 Mar; 228(5):726-7. PubMed ID: 16506935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]